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The Human Papillomavirus (HPV) has been strongly implicated in development of some cases of oral squamous cell carcinoma (OSCC). However, the immunological system 
somehow reacts against the presence of this virus. Among the cells involved in such 
mechanism of defense Langerhans cells (LC) stand out, which are responsible for processing 
and presenting antigens. Objectives: The purposes of this study were to investigate the 
presence of HPV DNA and to evaluate the immunohistochemical reactivity for Langerhans 
cells between HPV-positive and HPV-negative OSCC. Twenty-seven cases of OSSC were 
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Viral typing was performed by dot blot hybridization. Immunohistochemistry was performed 
by the Streptavidin-biotin technique. Results: From the 27 cases, 9 (33.3%) were HPV-
positive and 18 (66.0%) HPV-negative. HPV 18 was the most prevalent viral type (100% 
cases) and infection with HPV-16 (co-infection) was detected in only 1 case. In the OSCC 
specimens examined, immunoreactivity to S-100 antibody was detected in all cases, with 
a mean number of 49.48±30.89 Langerhans cells positive for immunostaining. The mean 
number of immunostained Langerhans cells was smaller in the HPV-positive cases (38 
cells/case) than in the HPV-negative cases (42.5 cells/case), but this difference was not 
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indicates a possible participation of the virus in the development and progression of only 
a subgroup of these tumors. There was no association between the immunohistochemical 
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that the presence of HPV in such OSCC cases could not alter the immunological system, 
particularly the Langerhans cells.
Key words: HPV. Carcinoma. Langerhans cells. Polymerase chain reaction. DNA probes.
INTRODUCTION
Oral squamous cell carcinoma (OSCC) is the 
most common type of cancer of the mouth, 
accounting for more than 90% of all malignant oral 
neoplasms. Smoking and alcohol are considered to 
be the main etiological factors of OSCC. However, 
some patients develop this neoplasm without 
exposure to these risk factors, a fact suggesting 
the involvement of other etiological factors such 
as viral agents, particularly human papillomavirus 
(HPV)4,5,15,24,30.
The role of HPV in the development of cancer of 
the uterine cervix has been well established, but the 
association between this virus and oral cancer is not 
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with the reported prevalence of HPV DNA in oral 
cancer tissue ranging from 0 to 100%3,12,15,22,25,30.
Cellular immunity seems to play an important 
role in the infection with HPV. The main cells 
involved in the elimination of altered cells are T 
lymphocytes. In the presence of an antigen, T cells 
need to be activated and this activation is mediated 
by antigen-presenting cells, including Langerhans 
cells13,14.
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epithelia of the epidermis and mucosa and 
their main function is to capture and transport 
protein antigens to the lymph nodes for effective 
presentation to T lymphocytes13. Thus, Langerhans 
cells are able to induce either a cellular or a humoral 
immune response14,29.
Langerhans cells are believed to play an 
important role in tumor immunology, exerting a 
function against the emergence of new antigens 
expressing malignant transformation20. The 
major cells involved in killing cancer are the T 
lymphocytes. However, T cells need to be activated 
upon antigen presentation, which is mediated by 
the antigen presenting cells, one of which is the 
Langerhans cell13,18.
Reduced immune surveillance may contribute 
to the severity of HPV-associated lesions8,12. Mota, 
et al.21 (1999) found a progressive decrease in the 
number of Langerhans cells with increasing severity 
of cervical intraepithelial lesions. In contrast, Levi, 
et al.16 (2005) observed an increase in the number 
of these cells with the progression of cervical 
neoplasms. In cancer of the uterine cervix, which 
is strongly associated with HPV, the onset and 
progression of this neoplasm are related to changes 
in Langerhans cells inside the squamous epithelium 
of this mucosa8,12.
The aims of the present study were to investigate 
the presence of HPV DNA and to compare the 
immunohistochemical staining of Langerhans cells 
between HPV-positive and HPV-negative cases of 
OSCC.
MATERIAL AND METHODS
Twenty-seven cases of OSCC were used in this 
study. All specimens were taken from formalin-
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Oral Pathology Laboratory, School of Dentistry, 
Federal University of Rio Grande do Norte and 
from archives of Dr. Luis Antonio Hospital, Natal, 
RN, Brazil.
Of the 27 cases of OSSC evaluated, tumor 
primary sites included lip (7 cases), tongue (4 
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63 years (range 30-93), the  sample comprised 19 
men an 8 women.
Ten 10-μm thick histological sections were 
obtained for DNA extraction and two 3-μm sections 
were stained with hematoxylin/eosin for review by 
a pathologist.
DNA was extracted using the ammonium 
acetate-isopropanol technique which does not 
require the use of phenol-chloroform. This method 
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in xylene heated to 65°C. Next, the tissues were 
hydrated in a decreasing ethanol series (absolute, 
95%, 70% and 50%). Then, 400 μL sterile lysis 
buffer (50 mM NaCl, 5 mM Tris-HCl, pH 8, 12.5 mM 
EDTA, pH 8, and 0.25% SDS) and proteinase K at a 
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tissue pellet of each sample and the samples were 
incubated at 55°C for 3 to 5 days until complete 
dissolution of the material. Next, 200 μL of a 4 M 
ammonium acetate solution was added to each 
sample for protein precipitation, followed by 600 
μL 100% isopropanol for DNA precipitation. Finally, 
the DNA pellets obtained were washed with 70% 
ethanol, dissolved in 50 μL TE buffer and stored 
at -20°C.
Polymerase Chain Reaction (PCR) was carried 
out in an Eppendorf thermocycler in a reaction 
mixture containing the following components in a 



Z<
_G
<	Z
_


!"B3 and PCO4 
primers (Invitrogen, Life Technologies, Carlsbad, 
CA, USA), 1.0 U Taq DNA polymerase (Invitrogen, 
Life Technologies), 20 mM Tris-HCl, pH 8.4, 50 mM 
KCl, 1.5 mM MgCl2, 200 μM dNTP (GE Healthcare, 
Little Chalfont, Bucknghamshire, UK), and 0.7 or 7 
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of the ß-globin gene were: initial denaturation at 
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at 95°C for 1 min, 50°C for 1 min and 72°C for 1 min, 
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PCR products were analyzed by electrophoresis on 
2.5% agarose gel (Nusieve, Cambrex Bio Science 
Rockland, Wokingham, Berkshire, United Kingdom) 
stained with ethidium bromide.
The samples positive for ß-globin were 
analyzed by PCR regarding the presence of 
HPV DNA using pair of generic primers GP5+ 
(5’TTTGTTACTGTGGTAGATACTAC3’) and GP6+ 
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a fragment of about 140 bp of the L1 gene, a highly 
conserved sequence in the genome of mucosal 
(genital and oral) HPVs. The use of this primer pair 
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segment from at least 23 individual mucosal (genital 
and oral) HPV types, including high-risk HPV types.
The reaction mixture contained 1.0 μM GP5+/
GP6+ (Invitrogen, Life Technologies), 1.0 U Taq 
DNA polymerase (Invitrogen, Life Technologies), 
20 mM Tris-HCl, pH 8.4, 50 mM KCl, 1.5 mM MgCl2, 
200 μM dNTP (GE Healthcare, Little Chalfont, 
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Figure 1- DNA detection by PCR in samples from patients 
with OSCC. Lanes 1-7: samples from patients; CP: Positive 
control- HeLa cell DNA infected with HPV18; CN: Negative 
control (H2O2); PM: Molecular marker (100 pb)
Figure 2- Immunostained Langerhans cells exhibiting 
characteristic dendritic shape. (SABC 400x)
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Buckinghamshire, UK), and 0.7 to 7.0 μL DNA, in 
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at 95°C for 1 min, 45°C for 2 min and 72°C for 
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mucosal (genital and oral) infections. Each dot blot 
membrane included several negative and positive 
controls for HPV types, as well as PCR products 
from patients and controls. The membrane was 
hybridized overnight as 56°C in 2x standard saline 
citrate (SSC), 0.5% sodium dodecyl sulfate (SDS) 
and 200 μg/mL DNA with 19 HPV types probes (6
,11,16,18,31,33,34,35,39,40,42,43,44,45,51,52,
54,56,58) and label [32P]dATP. After hybridization, 
the unbound probe was of 2x SSC and 0.5% SDS 
at room temperature and two 10-min washes of the 
same solution at 56°C. The membrane was exposed 
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Immunohistochemical staining was performed on 
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sections. The sections were mounted on glass slides 
previously treated with organosilane as adhesive 
(3-aminopropyltrietoxi-silan, Sigma Chemical Co., 
St. Louis, MO, USA). The immunohistochemical 
technique used was a streptavidin-biotin method 
(streptavidin-biotin complex). The sections were 
incubated with antibody against S-100 protein 
(clone Cow S-100, Dako Corporation, Carpinteria, 
CA, USA), 1:200 dilution for 2 h. The reaction was 
developed with diaminobenzidine as chromogen, 
and the sections were counterstained with Mayer’s 
hematoxylin. Section from nervous tissue was used 
protein-positive control. In negative controls, the 
primary antibody was omitted.
After immunohistochemistry, the immunoreactive 
cells were analyzed taking into the presence or 
absence of immunostaining (positive, negative), 
following immunostaining density established 
by the determination of the number of cells 
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immunohistochemical analysis, these data were 
correlated with a presence of HPV.
The results were analyzed statistically by the 
Fish and Mann-Whitney test. A level of statistical 
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This research was approved by Research Ethics 
Committee of the Federal University of Rio Grande 
do Norte (Process number 146/05).
RESULTS
With respect to HPV infection, of the 27 cases 
analyzed, 9 (33.3%) specimens were HPV-positive 
and 18 (66.7%) were HPV-negative. HPV-18 was 
detected in all 9 HPV-positive cases (100%) and 
infection with HPV-16 (co-infection) was detected 
in only 1 case (Figure 1).
The presence of Langerhans cells in the tumors 
was demonstrated by immunohistochemical 
staining for the anti-S-100 antibody, which 
resulted in a brown staining of the cytoplasm of 
cells with a dendritic shape (Figures 2 and 3). In 
the OSCC specimens analyzed, a mean number 
of 49.48±30.89 Langerhans cells were stained 
for the anti-S-100 antibody, ranging from 6 to 
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The median number of immunostained cells was 
smaller in HPV-positive cases (38 cells) compared to 
HPV-negative cases (42.5 cells), but this difference 
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of the presence or absence of HPV infection in 
relation to the number of S-100-stained Langerhans 
cells showed a wider variation in the number of 
immunostained cells in HPV-positive cases.
The possible association between the number 
of anti-S-100-positive Langerhans cells and HPV 
infection was also investigated. According with the 
median number of immunostained cells, cases were 
categorized into low (corresponding number of 
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HPV Infection Low High     p    
n (%) n (%)
Positive 7 (77.8%) 2 (22.2%)
Negative 15 (83.3%) 3 (16.7%) 1,000**
** Fisher test
Table 1- Cases categorized according with the median 
number of Langerhans cells immunostained, presence or 
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Figure 3- Immunostained Langerhans cells in a HPV-
positive case of oral squamous cell carcinoma (SABC 400x)
Immunohistochemical staining of Langerhans cells in HPV-positive and HPV-negative cases of oral squamous cells carcinoma
observed between the number of S-100-stained 
Langerhans cells and HPV-positive or HPV-negative 
cases of OSCC (p=1.000) (Table 1).
DISCUSSION
Oral cancer is a multifactorial disease, with 
smoking and regular alcohol consumption being 
the main etiological agents involved in oral 
carcinogenesis30. However, these habits do not 
always explain the development of this type of 
neoplasm5,11.
Over the last few years, HPV has called the 
attention of researchers as a possible etiological 
agent of oral cancer1,10,15,24. This virus is strongly 
associated with cancer of the uterine cervix 
and is detected in almost 100% of cases of this 
neoplasm, but its role in oral carcinogenesis is still 
inconclusive7,11,17,22,28,30.
Several techniques have been used for the 
detection of HPV, with PCR being considered the 
most sensitive method5. The most widely used 
primers are the generic primer pairs GP5+/GP6+ 
and MY09/MY11, which are able to amplify various 
virus types. In the present study, the presence 
or absence of HPV 
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small fragment (140 bp). This is important when 
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done in the present study. Nine cases of the present 
sample (33.3%) were HPV-positive and 18 (66.7%) 
were HPV-negative. This percentage is similar to 
data reported elsewhere15,26.
HPV-18 was detected in all HPV-positive cases, 
in agreement with previous studies4,19,26, in which 
HPV-18 was the most frequent type. However, other 
investigators1,3,11,15,17,28 detected HPV-16 in 71%, 
35%, 66.6%, 55.6%, 33.3% and 85% of cases, 
respectively, with this virus type being the most 
prevalent.
Local cellular immunity plays an important 
role in the response to infection with HPV and its 
progression in terms of neoplastic alterations6,8,9,12. 
Impaired immune function results in an increase of 
the frequency of clinically detected HPV infections8.
Langerhans cells are antigen-presenting and 
-processing cells present in the epithelium of skin 
and mucosa and are the main cell population 
responsible for the capture of antigens close to the 
epithelium, presenting these antigens to T helper 
cells (CD4+ T lymphocytes) and thus inducing a 
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the evaluation of the patient’s immune system 
is the investigation of Langerhans cells in the 
epithelium14,18.
It has been suggested that HPV infection exerts 
an immunosuppressive effect, reducing the number 
of Langerhans cells in the epithelium of lesions 
infected with this virus6,9,12,21.
Th is  suggest ion has  encouraged the 
present investigation, which analyzed the 
immunohistochemical staining of Langerhans cells 
in cases of OSCC infected with HPV, a fact not 
described in the literature.
All 27 OSCC specimens analyzed presented 
positive staining for Langerhans cells (S-100+), 
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Sobhani, et al.27 (2002) and Karakök, et al.13 
(2003), who investigated cases of OSCC, cervical 
intraepithelial lesions and laryngeal carcinoma, 
respectively.
In the present study, a mean number of 49.48 
Langerhans cells were stained for the anti-S-100 
antibody in each case. This result differs from 
those reported by Connor, et al.6 (1999), who 
observed 6.0±2.3 immunostained Langerhans cells 
in high-grade cervical intraepithelial lesions, and 
Karakök, et al.13 (2003), who found 5.3±7.9 S-100+ 
Langerhans cells in squamous cell carcinoma of 
the larynx. Hubert, et al.9 (2005) detected about 3 
Langerhans cells in cervical carcinomas, whereas 
Levi, et al.16 (2005) found a mean number of 6.1 
immunostained Langerhans cells in high-grade 
intraepithelial neoplasms. These discrepant results 
might be attributed to the heterogeneity in the 
types of lesions analyzed, as well as to the different 
sites of the lesions since, despite similarities, each 
mucosa presents its peculiarities.
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Miyagi, et al.20 (2001) detected a larger number 
of Langerhans cells in tumors infected with HPV 
(more than 100 cells per
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not infected with this virus (fewer than 10 cells 
per
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squamous cell carcinoma of the lung. In the present 
study, we found a wide variation in the number of 
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was observed between the number of Langerhans 
cells and the presence of HPV in the OSCC cases 
	
B
 
 +

 
 +
 

Uchimura, et al.29 (2004), who did not observe 
differences in the density of Langerhans cells in 
cervical lesions between HPV-positive and HPV-
negative groups. However, these authors noted a 
change in the morphology of these cells from their 
characteristic dendritic shape to a more round shape 
in HPV-positive cases. This fact was not observed 
in the present study. This divergence between the 
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the lesions, in view of the fact that the oral mucosa 
markedly differs from the cervical and pulmonary 
epithelium.
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between the number of Langerhans cells and the 
presence of HPV, the number of S-100+ cells 
tended to be smaller in HPV-positive cases. In 
agreement with this observation, Connor, et al.6 
(1999) and Jimenez-Flores, et al.12 (2006) found 
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cases of HPV-positive cervical neoplasms compared 
to HPV-negative lesions. We agree with Arany and 
Tyring2 (1998) who suggested that this depletion 
of Langerhans cells is apparently associated with 
replication of HPV since oncoproteins of this virus 
may affect antigen presentation.
Jimenez-Flores, et al.12 (2006) suggest that 
there is not a precise explanation for the decrease 
of dendritic cells found in the HPV-infected cervix, 
although several possibilities exist, including: 
reduction of the dendritic cells (or their immediate 
precursors) colonizing this area; increased exiting 
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dendritic cell death. They believe that the last 
possibility, although feasible, is less likely to occur 
because HPV is known to induce proliferation rather 
than cell death, at least in epithelial cells.
When classifying the mean number of Langerhans 
cells into high and low, we found no association 
between the number of these cells and HPV-positive 
or HPV-negative cases. Though, we believe that HPV 
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microenvironment. According to Gianini, et al.8 
(2002) and Jimenez-Flores, et al.12 (2006), a 
consequence of this could be a more permissive 
microenvironment for the HPV to initiate and 
establish infection within the regional tissue, so 
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recruitment into this microenvironment.
So far, no study is available correlating 
Langerhans cells and HPV in OSCC, a fact impairing 
the comparison of the present data with the 
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may provoke changes in the immune system by 
interfering with Langerhans cell-associated antigen 
presentation, permitting the escape from this 
defense mechanism. However, the present results 
showed no interference of HPV with Langerhans 
cells in the OSCC cases analyzed.
CONCLUSION
In conclusion, we observed no association 
between the immunostaining of Langerhans cells 
(S-100+) and infection with HPV in the OSCC cases 
analyzed. Despite the reduced sample analyses, 
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cases, which led to the exclusion these, our 
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cases of OSCC could not alter the immunological 
system, particularly the Langerhans cells. Further 
studies will be necessary to understand the real 
role between Langerhans cells and HPV in oral 
carcinogenesis.
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